Powered by
Tags
Vaccines

Overview

Denteric is a clinical stage biotech company developing therapies with the potential to treat multiple chronic diseases associated with inflammation caused by Porphyromonas gingivalis toxins. Our lead product is for treatment of severe periodontal disease which affects 1 billion adults globally.

Delegates

Photogrpah by Christopher Hopkins
Larisa Chisholm
Chief Operating Officer
Head-shot-2_Square_PC-scaled-1.jpg
Paul Cockle
Chief Scientific Officer
Chris Smith
Director